Related Experiment Video
Updated: Jan 16, 2026
Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
CPMOAD: comprehensive preeclampsia multi-omics analysis database
Yang Fang1,2,3, Mengzhe Fan4, Hao Li5,6
1Department of Laboratory Medicine, The Third Affiliated Hospital of Zhengzhou University, 7 Kangfu Qian Street, Zhengzhou, 450052, Henan, People's Republic of China. yangfangscu@gmail.com.
Insights
A new database, CPMOAD, integrates multi-omics data for preeclampsia (PE) research. This comprehensive resource aids in discovering molecular mechanisms and biomarkers for improved maternal and fetal health outcomes in PE.
Area of Science:
- Genomics
- Biotechnology
- Reproductive Medicine
Background:
- Preeclampsia (PE) is a significant global health concern during pregnancy, affecting maternal and fetal well-being.
- Existing multi-omics datasets for PE are fragmented, hindering comprehensive analysis and discovery.
- A unified platform for integrating and analyzing diverse PE-related omics data is critically needed.
Purpose of the Study:
- To develop a centralized online platform for integrating and analyzing preeclampsia multi-omics data.
- To provide researchers with tools for exploring gene expression, DNA methylation, and molecular interactions in PE.
- To facilitate the discovery of novel molecular mechanisms and biomarkers for preeclampsia.
Main Methods:
- Developed CPMOAD (Comprehensive Preeclampsia Multi-Omics Analysis Database), an integrated online platform.
- Integrated RNA-seq, DNA methylation, and literature-curated data for preeclampsia.
- Applied uniform processing for differential expression, methylation analysis, and molecular interaction records.
Main Results:
- CPMOAD provides access to diverse PE data, including gene expression and methylation profiles.
- The platform enables interactive differential expression, methylation, and pathway enrichment analyses.
- Users can explore validated molecular signatures associated with preeclampsia through the web interface.
Conclusions:
- CPMOAD is a comprehensive, user-friendly resource for integrated multi-omics analysis in preeclampsia research.
- The database aims to accelerate the identification of molecular mechanisms and biomarkers for PE.
- CPMOAD is freely accessible, promoting collaborative research in preeclampsia.
Background:
Preeclampsia (PE) is a pregnancy-specific syndrome that poses serious risks to both maternal and fetal health globally. Despite the accumulation of multi-omics datasets from various studies, a unified platform that integrates these resources for comprehensive analysis remains unavailable.
Methods:
We developed CPMOAD (Comprehensive Preeclampsia Multi-Omics Analysis Database), an online platform designed to integrate RNA-seq, DNA methylation, and literature-curated data related to PE. All datasets were uniformly processed to generate differential expression profiles, methylation data, and curated molecular interaction records. The database is equipped with interactive visualization tools and customizable analysis modules.
Results:
CPMOAD offers access to a broad spectrum of PE-relevant data, including gene expression and methylation profiles. Users can perform differential expression analysis, methylation analysis, and pathway enrichment analysis directly through the web interface. The platform also enables the exploration of validated molecular signatures associated with PE.
Conclusions:
CPMOAD serves as a comprehensive and user-friendly resource for integrated multi-omics analysis in preeclampsia research. By consolidating diverse datasets and providing powerful analytical tools, CPMOAD aims to accelerate the discovery of molecular mechanisms and potential biomarkers for PE. The database is freely accessible at http://nscc.zzu.edu.cn/CPMOAD/ .
